4//SEC Filing
Kalb Michael Wayne 4
Accession 0001161697-26-000022
CIK 0001369568other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:00 PM ET
Size
9.3 KB
Accession
0001161697-26-000022
Insider Transaction Report
Form 4
Kalb Michael Wayne
Executive Vice President & CFO
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2026-01-05+7,139→ 15,745 total - Tax Payment
Common Stock, par value $0.001 per share
2026-01-05−2,080→ 13,665 total - Exercise/Conversion
Restricted Stock Units
2026-01-05−7,139→ 632,903 total→ Common Stock (7,139 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.
- [F3]Derivative securities vest in equal tranches, 1/5th on January 1, 2025, 1/5th on January 1, 2026, 1/5th on January 1, 2027, 1/5th on January 1, 2028, and 1/5th on January 1, 2029.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on January 5, 2026.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001678248
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:00 PM ET
- Size
- 9.3 KB